¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22
±³À°ÀÏÀÚ : 2024-06-22
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ4F

±³À°ÁÖÁ¦ : 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹¸Á¸·ÇÐȸ

´ã´çÀÚ : ¹ÚÀ±Á¤
¿¬¶ôó : 02-471-6520

À̸ÞÀÏ : retina@retina.or.kr

±³À°Á¾·ù : ¾È°ú

Âü¼®¿¹»óÀÎ : 170¸í
Èñ¸ÁÆòÁ¡ : 1Á¡

Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 1 ½Ã°£ 36ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:00~09:08 (ÃÊ·Ï)Asian Subgroup Analysis of a Phase III Study Comparing SB15 with Reference Aflibercept (Eylea) in Neovascular Age-related Macular Degeneration ÀÌÁÖ¿ë(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:08~09:16 (ÃÊ·Ï)Real-world incidence and risk factors of incident non-infectious uveitis in patients treated with Immune checkpoint inhibitors ±è¿ëÁØ(¿¬¼¼´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:16~09:24 (ÃÊ·Ï)Progression of myopia and related structural changes in retina: school-based prospective cohort study ¹è°ÇÈ£(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:24~09:32 (ÃÊ·Ï)Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea Áöµ¿Çö(°¡Å縯´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:32~09:40 (ÃÊ·Ï)Case series of branch retinal vein occlusion secondary to rhegmatogenous retinal detachment and its surgical management ¹Ú¼ºÈÄ(ºÎ»ê´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:40~09:48 (ÃÊ·Ï)Prevalence and Risk Factors of Age-related Macular Degeneration in South Korea: Korea National Health and Nutrition Examination Survey 2017-2020 ±èÀçÈÖ(±è¾È°úº´¿ø)

ÈÞ½Ä 06¿ù 22ÀÏ 09:48~09:55 ÈÞ½Ä -(-)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:55~10:03 (ÃÊ·Ï)Introducing New Retinal Vessel Analysis Software: SEoul Retinal Vessel Assessment Library (SERVAL) ¹Ú»óÁØ(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:03~10:11 (ÃÊ·Ï)Multimodal deep learning-based prediction of treatment response in diabetic macular edema À±Á¦¹®(¼º±Õ°ü´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:11~10:19 (ÃÊ·Ï)A novel fluorescent diagnostic agent targeting choroidal neovascularization Ãֽ¿ì(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:19~10:27 (ÃÊ·Ï)Epiretinal Membrane: Exploring Correlations between Clinical and immunohistochemical Characteristics and Their Prognostic Implications ¾çÇö½Â(¼­¿ï½Å¼¼°è¾È°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:27~10:35 (ÃÊ·Ï)Changes in the outer nuclear layer and choroidal vascularity during the manifest and quiescent phases of acute central serous chorioretinopathy ¼­ÀÇÁ¾(ÃæºÏ´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:35~10:43 (ÃÊ·Ï)Macular microvasculature asymmetry in high myopia patients with open-angle glaucoma À̹οì(°Ç¾ç´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Á¦7ȸ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾îÁö·³Áõ¼¾ÅÍ ¿¬¼ö°­Á : 2024-06-22
´ÙÀ½±Û ´ëÇÑÃé´ãµµÇÐȸ [¿Â¶óÀÎ] Pancreato-Biliary Summer School 2024 (PB-SS) : 2024-06-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
138 ¼­¿ï Á¦14ȸ ÀÓ»óÀÌ°úÇм¼¹Ì³ª(´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ&´ëÇÑÀÌÇÐȸ °øµ¿ÁÖ°ü) : 2018-08-26 0 654 2018-07-28
137 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø Á¦4ȸ Áß¾Ó´ëÇб³ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2018-08-26 0 478 2018-07-28
136 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø 13th Yonsei Foot & Ankle Cadaveric Workshop : 2018-08-26 0 409 2018-07-28
135 °æ±â Á¦59ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ¼¼¹Ì³ª : 2018-08-26 0 1,844 2018-07-28
134 ¼­¿ï Á¦8ȸ »ï¼º¼­¿ïº´¿ø ¼Ò¾Æû¼Ò³â¼¾ÅÍ ½ÉÆ÷Áö¾ö(ÁÖÁ¦: ÈçÈ÷ ¸¸³ª°Ô µÇ´Â ¼Ò¾Æû¼Ò³â Áúȯ) : 2018-08-26 0 723 2018-07-28
133 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦9ȸ ¿¬¼¼ÀÇ´ë ¼Ò¾Æ°úÇб³½Ç, ¼Ò¾Æ¾Ë·¹¸£±âÈ£Èí±âÁúȯ ¿¬¼ö°­Á : 2018-08-26 0 395 2018-07-28
132 ¼­¿ï 2018 ´ëÇѼö¸éÇÐȸ ¿öÅ©¼¥ : 2018-08-26 0 482 2018-07-28
131 °æºÏ ´ëÇѼҾưúÇÐȸ ¼Ò¾Æû¼Ò³â°ú ¿Ü·¡¿¡¼­ Àû¿ë °¡´ÉÇÑ ÀÓ»óÁö½Ä : 2018-08-26 0 652 2018-07-28
130 °æ³² ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ 2018 Post Graduate Asthma School (2ÀÏÂ÷) : 2018-08-26 0 1,080 2018-07-28
129 ¼­¿ï Á¦5ȸ ´ëÇÑ°³¿ø³»°úÀÇ»çȸ °¨¿°º´ ¹× ¹é½Å½ÉÆ÷Áö¿ò : 2018-08-26 0 527 2018-07-28
128 ¼­¿ï Á¦15Â÷ °æ±âµµÀÇ»çȸ Çмú´ëȸ : 2018-08-26 0 1,154 2018-07-28
127 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ °í/½½°üÀý Áúȯ : 2018-08-25 0 565 2018-07-28
126 ºÎ»ê ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2018 ECMO Symposium and Simulation Workshop : 2018-08-25 0 2,513 2018-07-28
125 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_ÃÊÀ½ÆÄ¿öÅ©¼ó : 2018-08-25 0 629 2018-07-28
124 ´ëÀü Ãæ³²´ëÇб³º´¿ø Ãæ³²´ëÇб³ ½Å°æ¿Ü°ú ȨĿ¹Ö ½ÉÆ÷Áö¿ò : 2018-08-25 0 902 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷